OB-GYN Clinical Trials
When you seek care at an academic medical center like UK HealthCare, your treatment is backed up by leading-edge discoveries made by our researchers. And you have the opportunity to participate in innovative clinical trials that offer you the latest treatment options.
Current trial titles
11-GYN-098-MCC: A Non-randomized Neoadjuvant Platinum-based Chemotherapy in Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma Trial Protocol (IRB #11-0903-F3R)
11-GYN-130: Treatment of Endometrial Cancer Utilizing Pathology Intraoperative Consultation to Determine Extent of Surgical Staging (IRB #11-0901-F6A)
GOG-0238: A Randomized Trial Of Pelvic Irradiation With Or Without Concurrent Weekly Cisplatin In Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus (IRB #08-0769-F1V)
GOG-0258: A Randomized Phase III Trial Of Cisplatin And Tumor Volume Directed Irradiation Followed By Carboplatin And Paclitaxel Vs. Carboplatin And Paclitaxel For Optimally Debulked, Advanced Endometrial Carcinoma (IRB #09-0902-F1V)
GOG-0260: A Phase II Evaluation of Elesclomol Sodium and Weekly Paclitaxel in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer (IRB #11-0350-F6A)
GOG-0261: A Randomized Phase III Trial of Paclitaxel plus Carboplatin versus Ifosfamide plus Paclitaxel in Chemotherapy- Naive Patients with Newly Diagnosed Stage I-IV Persistent or Recurrent Carcinoma (Mixed Mesodermal Tumors) of the Uterus (IRB #10-0067-F6A)
GOG-0263: Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA, Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic Lymphadenectomy (IRB #11-0556-F6A)
GOG-3001 (Trinova-3, Amgen 20101129/ENGOT-ov2): A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers (IRB #13-0274-F1V)
88-GYN-13: Transvaginal Ultrasonography As a Screening Method for Ovarian Cancer
Complete trial information
Protocol No.
11-GYN-098-MCC
Title
11-GYN-098-MCC: A Non-randomized Neoadjuvant Platinum-based Chemotherapy in Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma Trial Protocol (IRB #11-0903-F3R)
PI Name
Miller, Rachel, W
Phase
Phase II
Protocol Type
Therapeutic intervention
Summary 4 Type
Agent/Device
Age Group
Adults
Sponsor Type
Institutional
Protocol No.
11-GYN-130
Title
11-GYN-130: Treatment of Endometrial Cancer Utilizing Pathology Intraoperative Consultation to Determine Extent of Surgical Staging (IRB #11-0901-F6A
PI Name
Ueland, Frederick
Phase
Phase II
Protocol Type
Therapeutic intervention
Summary 4 Type
Agent/Device
Age Group
Adults
Sponsor Type
Institutional
Protocol No.
GOG-0238
Title
GOG-0238: A Randomized Trial Of Pelvic Irradiation With Or Without Concurrent Weekly Cisplatin In Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus (IRB #08-0769-F1V
PI Name
Ueland, Frederick
Phase
Phase II
Protocol Type
Therapeutic intervention
Summary 4 Type
Agent/Device
Age Group
Adults
Sponsor Type
National group
Protocol No.
GOG-0258
Title
GOG-0258: A Randomized Phase III Trial Of Cisplatin And Tumor Volume Directed Irradiation Followed By Carboplatin And Paclitaxel Vs. Carboplatin And Paclitaxel For Optimally Debulked, Advanced Endometrial Carcinoma (IRB #09-0902-F1V)
PI Name
Ueland, Frederick
Phase
Phase III
Protocol Type
Therapeutic intervention
Summary 4 Type
Agent/Device
Age Group
Adults
Sponsor Type
National group
Protocol No.
GOG-0260
Title
GOG-0260: A Phase II Evaluation of Elesclomol Sodium and Weekly Paclitaxel in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer (IRB #11-0350-F6A)
PI Name
Ueland, Frederick
Phase
Phase II
Protocol Type
Therapeutic intervention
Summary 4 Type
Agent/Device
Age Group
Adults
Sponsor Type
National group
Protocol No.
GOG-0261
Title
GOG-0261: A Randomized Phase III Trial of Paclitaxel plus Carboplatin versus Ifosfamide plus Paclitaxel in Chemotherapy- Naive Patients with Newly Diagnosed Stage I-IV Persistent or Recurrent Carcinoma (Mixed Mesodermal Tumors) of the Uterus (IRB #10-0067-F6A)
PI Name
Ueland, Frederick
Phase
Phase III
Protocol Type
Therapeutic intervention
Summary 4 Type
Agent/Device
Age Group
Adults
Sponsor Type
Institutional
Protocol No.
GOG-0263
Title
GOG-0263: Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA, Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic Lymphdenectomy (IRB #11-0556-F6A)
PI Name
Ueland, Frederick
Phase
Phase III
Protocol Type
Therapeutic intervention
Summary 4 Type
Agent/Device
Age Group
Adults
Sponsor Type
National group
Protocol No.
GOG-3001
Title
GOG-3001 (Trinova-3, Amgen 20101129/ENGOT-ov2): A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers (IRB #13-0274-F1V)
PI Name
Ueland, Frederick
Phase
Phase III
Protocol Type
Therapeutic intervention
Summary 4 Type
Agent/Device
Age Group
Adults
Sponsor Type
National group
Protocol No.
88-GYN-13
Title
Transvaginal Ultrasonography As a Screening Method for Ovarian Cancer
PI Name
van Nagell Jr., John
Phase
NA
Protocol Type
Screening, Early Detection or Diagnosis
Summary 4 Type
Other interventions
Age Group
Adults
Sponsor Type
Institutional